Farallon Capital Partners L.P. 13D and 13G filings for Elevation Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-08 11:54 am Purchase | 2024-09-30 | 13G | Elevation Oncology, Inc. ELEV | Farallon Capital Partners L.P. | 3,527,482 6.000% | 427,482 (+13.79%) | Filing |
| 2024-01-22 09:02 am Purchase | 2024-01-12 | 13G | Elevation Oncology, Inc. ELEV | Farallon Capital Partners L.P. | 3,100,000 7.300% | 3,100,000 (New Position) | Filing |